| Certification: | CE, ISO13485 |
|---|---|
| Certificate: | ISO, CE |
| Transport Package: | Box+Carton |
| Trademark: | OBM/OEM |
| Origin: | China |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Intended Use
Due to the emergence, spread, and persistence of multidrug- resistant (MDR) bacteria or "superbugs", Antimicrobial resistance (AMR)poses a serious global threat of growing concern to human, animal, and environment.
Enterobacterales are conditionally pathogenic bacteria that cause serious hospital-acquired infections. The spread of carbapene-mase-producing Enterobacterales has become a major global public health threat. Carbapenems have traditionally been used to treat infections caused by broad-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae and are still considered antibiotics to be used as antibiotic of choice. At present, the common carbapenemases mainly include KPC, IMP, NDM, VIM and OXA-48 like types.
Accurate and quick detection of CRE is of great significance for clinical prevention and treatment.
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}